What is Neosensory?
Neosensory specializes in developing award-winning technology for tinnitus relief and hearing loss. Their core innovation lies in a patented wristband that leverages a scientific foundation to retrain the brain's response to auditory stimuli. While the company has transitioned its technology to another organization, its legacy is built on a commitment to providing effective, non-invasive solutions for individuals experiencing auditory challenges. The scientific underpinnings of their approach have positioned them as a notable entity in the health-tech sector.
How much funding has Neosensory raised?
Neosensory has raised a total of $14.2M across 2 funding rounds:
Private Equity
$4.2M
Series A
$10M
Private Equity (2015): $4.2M, investors not publicly disclosed
Series A (2019): $10M, investors not publicly disclosed
What's next for Neosensory?
The recent major strategic investment signifies a pivotal moment for Neosensory, suggesting a renewed focus on the advancement and potential future deployment of its technology. Although the company has transitioned its core operations, the influx of capital indicates confidence in the underlying intellectual property and its market potential. This strategic backing is likely to facilitate further research, development, or a potential reintroduction of their products, aiming to address the significant market need for effective hearing loss and tinnitus solutions. The company's future trajectory will be closely watched as it navigates this new phase.
See full Neosensory company page
